Moshkevich Solomon sold 954 shares of Natera, Inc. at $413.11 for −$394k on Oct 1, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
PRESIDENT, CLINICALDIAGNOSTICS
PRESIDENT, CLINICALDIAGNOSTICS
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$394,103.70Shares × reported price
Shares traded
954Common Stock
Price per share
$413.11Reported price. Read footnotes for ranges.
% of reported position traded
0.87%This security and ownership context
Holdings after
108,760Direct
Trade date
Oct 1, 2026Sell
Filed
Oct 2, 2026, 9:35 PM ET2-day reporting delay
Accession
0002010019-26-000030Code S · Transaction 236193
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 109,714 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 1, 2026Sell200$411.62−$82,324Trade 236192
Oct 1, 2026Sell1,846$415.07−$766,217.56Trade 236194
3 transaction rows in this filing. Joint filers share the same rows.

NTRA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NTRA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −22%1w ago −0.4%1d ago +0.7%
Returns since7d −2.3%30d +1%90d180d1y

Footnotes in full

F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024. F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $411.55 to $411.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $412.8350 to $413.3100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.44 to $415.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.